Trial Profile

An open-label, randomized, parallel group study comparing the efficacy and safety of amlodipine in combination with valsartan compared to losartan in combination with hydrochlorothiazide given for 52 weeks on the regression of left ventricular hypertrophy in patients with mild to moderate hypertension.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 10 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Amlodipine (Primary) ; Valsartan (Primary) ; Hydrochlorothiazide; Losartan
Indications Essential hypertension
Focus Therapeutic Use
Sponsors Novartis

26 Apr 2011 Actual end date (1 Mar 2010) added as reported by ClinicalTrials.gov.
26 Apr 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
21 Sep 2007 Status changed from recruiting to in progress.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com